Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lesli Ivett Jimenez Garcia
Observed names:
L. García,
Lara María Gómez García
Institutions:
Hospital Clínico Universitario de Valladolid,
Benemérita Universidad Autónoma de Puebla
Observed institutions:
Hospital General De Segovia,
Hospital Clínico Universitario de Valladolid,
Benemérita Universidad Autónoma de Puebla
ORCID:
0000-0001-8816-9027
Observed ORCID:
0000-0001-8816-9027
OpenAlex ID:
A5022532147
Venetoclax in combination with hypomethylating agents in adult patients with newly diagnosed AML with CBFB::MYH11 or RUNX1::RUNX1T1 fusions: Real-world outcomes based on international registry data
2025
·
Leo Ruhnke
, Christoph Röllig
, et al.
·
Blood
·
2
PDF
Tumor-infiltrating lymphocyte (TIL) therapy for immunotherapy-refractory advanced melanoma: a systematic review of response and survival rates
2025
·
Lesli Ivett Jimenez Garcia
, Samira Dayuma Asquel Caiza
, et al.
·
Ibero-American Journal of Health Science Research
·
1
PDF
837P Real-world evidence of encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma in Spain (GEM 2002 - BECARE)
2022
·
A. Soria
, P. Sánchez Mauriño
, et al.
·
Annals of Oncology
·
1
Show more works
View as search
Works count:
3
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type